| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 4.53e-09 | 441 | 71 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 4.75e-08 | 11 | 71 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 2.19e-07 | 614 | 71 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 2.97e-06 | 775 | 71 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 5.08e-06 | 10 | 71 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 7.04e-06 | 839 | 71 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 7.13e-06 | 840 | 71 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8A2 NAIP ABCD3 CHD7 INO80 POLQ DNAH8 ATP2B1 ATP2B2 ATP2B3 ATP2B4 HSP90AA1 HSP90AB1 | 7.13e-06 | 840 | 71 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.93e-06 | 36 | 71 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.93e-06 | 36 | 71 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | transporter activity | LRRC8E CACNA1C SEC61A2 ZACN SLC36A4 ATP8A2 HPX SLC6A5 ABCD3 SLC5A12 SEC61A1 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.02e-06 | 1289 | 71 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | CTP binding | 1.25e-05 | 2 | 71 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | LRRC8E CACNA1C SEC61A2 ZACN SLC36A4 HPX SLC6A5 ABCD3 SLC5A12 SEC61A1 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.37e-05 | 1180 | 71 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.62e-05 | 151 | 71 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 3.73e-05 | 3 | 71 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.32e-05 | 109 | 71 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC36A4 SLC6A5 ABCD3 SLC5A12 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.70e-05 | 477 | 71 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ZACN OR5AK2 AGTR2 NTSR1 TLR4 OR4C46 OR52E5 IL20RA OR5A2 OR5K2 ADGRA1 OR5K1 IL1RL2 OR1L1 CNTFR | 6.71e-05 | 1353 | 71 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 7.01e-05 | 62 | 71 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | UTP binding | 7.44e-05 | 4 | 71 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 1.24e-04 | 5 | 71 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 1.24e-04 | 5 | 71 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.68e-04 | 230 | 71 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.85e-04 | 6 | 71 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.40e-04 | 465 | 71 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 2.59e-04 | 7 | 71 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | TPR domain binding | 3.44e-04 | 8 | 71 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 4.31e-04 | 178 | 71 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 4.42e-04 | 9 | 71 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | LRRC8E CACNA1C ZACN SLC6A5 SLC5A12 SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.75e-04 | 793 | 71 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C ZACN SLC6A5 SLC5A12 SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.57e-04 | 664 | 71 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 6.72e-04 | 11 | 71 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.03e-04 | 301 | 71 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 8.42e-04 | 431 | 71 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 8.53e-04 | 207 | 71 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 8.71e-04 | 208 | 71 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 9.69e-04 | 123 | 71 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | odorant binding | 1.09e-03 | 127 | 71 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5AK2 AGTR2 NTSR1 OR4C46 OR52E5 OR5A2 OR5K2 ADGRA1 OR5K1 OR1L1 | 1.10e-03 | 884 | 71 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.10e-03 | 14 | 71 | 2 | GO:0003964 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.45e-03 | 16 | 71 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.69e-03 | 627 | 71 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.07e-03 | 71 | 71 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 3.01e-03 | 23 | 71 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | death receptor binding | 3.55e-03 | 25 | 71 | 2 | GO:0005123 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.89e-03 | 293 | 71 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 4.13e-03 | 27 | 71 | 2 | GO:0023026 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 4.44e-03 | 28 | 71 | 2 | GO:0008320 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 5.00e-03 | 97 | 71 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.37e-03 | 758 | 71 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.23e-03 | 105 | 71 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 6.50e-03 | 34 | 71 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.88e-03 | 35 | 71 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.66e-03 | 37 | 71 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.07e-03 | 38 | 71 | 2 | GO:0034061 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 8.48e-03 | 39 | 71 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 8.91e-03 | 40 | 71 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 9.35e-03 | 41 | 71 | 2 | GO:0016799 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 9.35e-03 | 41 | 71 | 2 | GO:0023023 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 9.35e-03 | 41 | 71 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | protein transporter activity | 9.79e-03 | 42 | 71 | 2 | GO:0140318 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.05e-02 | 127 | 71 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | tau protein binding | 1.17e-02 | 46 | 71 | 2 | GO:0048156 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.47e-06 | 163 | 71 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.73e-06 | 167 | 71 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 2.87e-06 | 29 | 71 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5AK2 ATP8A2 NTSR1 TLR4 OR4C46 OR52E5 OR5A2 OR5K2 OR5K1 ATP2B2 OR1L1 | 4.54e-06 | 582 | 71 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5AK2 ATP8A2 NTSR1 TLR4 NAIP OR4C46 OR52E5 OR5A2 OR5K2 OR5K1 ATP2B2 OR1L1 | 5.95e-06 | 722 | 71 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C NTSR1 CHD7 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 7.77e-06 | 392 | 71 | 9 | GO:0070588 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.42e-05 | 230 | 71 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 1.60e-05 | 326 | 71 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.37e-05 | 249 | 71 | 7 | GO:0008016 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.45e-05 | 100 | 71 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 3.19e-05 | 359 | 71 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | eye development | 3.85e-05 | 480 | 71 | 9 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 4.04e-05 | 483 | 71 | 9 | GO:0150063 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.39e-05 | 611 | 71 | 10 | GO:0030003 |
| GeneOntologyBiologicalProcess | sensory system development | 4.59e-05 | 491 | 71 | 9 | GO:0048880 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 4.75e-05 | 58 | 71 | 4 | GO:0089718 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 5.00e-05 | 116 | 71 | 5 | GO:0008344 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.10e-05 | 622 | 71 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.10e-05 | 622 | 71 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 5.62e-05 | 389 | 71 | 8 | GO:0055074 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 5.87e-05 | 120 | 71 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C NTSR1 CHD7 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 6.05e-05 | 509 | 71 | 9 | GO:0006816 |
| GeneOntologyBiologicalProcess | sensory perception | OR5AK2 HMCN1 ATP8A2 NTSR1 TLR4 OR4C46 OR52E5 OR5A2 OR5K2 CHD7 OR5K1 ATP2B2 OR1L1 | 6.56e-05 | 1072 | 71 | 13 | GO:0007600 |
| GeneOntologyBiologicalProcess | calcium ion export | 6.98e-05 | 4 | 71 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | adult behavior | 7.10e-05 | 203 | 71 | 6 | GO:0030534 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1C AGTR2 NTSR1 CHD7 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 HSP90AA1 | 7.17e-05 | 648 | 71 | 10 | GO:0008015 |
| GeneOntologyBiologicalProcess | heart contraction | 7.39e-05 | 298 | 71 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 8.11e-05 | 410 | 71 | 8 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 8.39e-05 | 412 | 71 | 8 | GO:0015849 | |
| GeneOntologyBiologicalProcess | heart process | 9.26e-05 | 309 | 71 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.06e-04 | 426 | 71 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | LRRC8E CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.20e-04 | 981 | 71 | 12 | GO:0019725 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1C ZACN NTSR1 HPX SLC6A5 CHD7 SLC5A12 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.41e-04 | 1157 | 71 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1C NTSR1 HPX SLC6A5 CHD7 SLC5A12 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.43e-04 | 1000 | 71 | 12 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.43e-04 | 705 | 71 | 10 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.65e-04 | 717 | 71 | 10 | GO:0050801 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1C AGTR2 NTSR1 HPX CHD7 FASLG SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.71e-04 | 866 | 71 | 11 | GO:0055082 |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid translocation | 1.74e-04 | 6 | 71 | 2 | GO:0061092 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 1.74e-04 | 6 | 71 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.93e-04 | 83 | 71 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C AGTR2 NTSR1 CHD7 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 HSP90AA1 | 1.97e-04 | 733 | 71 | 10 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of system process | CACNA1C TENM4 AGTR2 NTSR1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 HSP90AA1 | 1.99e-04 | 734 | 71 | 10 | GO:0044057 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 2.02e-04 | 84 | 71 | 4 | GO:0051480 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | LRRC8E CACNA1C ZACN NTSR1 HPX SLC6A5 CHD7 SLC5A12 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.11e-04 | 1374 | 71 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | behavior | CACNA1C NTAN1 ATP8A2 AGTR2 NTSR1 CHD7 SLC7A11 ATP2B2 PTGS1 CNTFR SEZ6L | 2.19e-04 | 891 | 71 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 2.31e-04 | 87 | 71 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid translocation | 2.43e-04 | 7 | 71 | 2 | GO:0061091 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | LRRC8E CACNA1C AGTR2 CAPZA2 ATP2B1 ATP2B2 PTGS1 HSP90AA1 HSP90AB1 | 2.61e-04 | 618 | 71 | 9 | GO:0090066 |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 3.23e-04 | 8 | 71 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 3.23e-04 | 8 | 71 | 2 | GO:0031204 | |
| GeneOntologyBiologicalProcess | regulation of glutamine family amino acid metabolic process | 3.23e-04 | 8 | 71 | 2 | GO:0000820 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.27e-04 | 39 | 71 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 3.51e-04 | 97 | 71 | 4 | GO:0045428 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1C ZACN NTSR1 SLC6A5 CHD7 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.53e-04 | 942 | 71 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | organic anion transport | 3.83e-04 | 515 | 71 | 8 | GO:0015711 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | LRRC8E CACNA1C ZACN NTSR1 SLC6A5 CHD7 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.90e-04 | 1115 | 71 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 3.94e-04 | 100 | 71 | 4 | GO:0080164 | |
| GeneOntologyBiologicalProcess | neural retina development | 4.25e-04 | 102 | 71 | 4 | GO:0003407 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 4.30e-04 | 524 | 71 | 8 | GO:0009593 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 4.37e-04 | 284 | 71 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 5.27e-04 | 108 | 71 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | amino acid transport | 5.63e-04 | 195 | 71 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 6.05e-04 | 112 | 71 | 4 | GO:0006809 | |
| GeneOntologyBiologicalProcess | negative regulation of norepinephrine secretion | 6.30e-04 | 11 | 71 | 2 | GO:0010700 | |
| GeneOntologyBiologicalProcess | nitric oxide-cGMP-mediated signaling | 6.30e-04 | 11 | 71 | 2 | GO:0038060 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 6.47e-04 | 114 | 71 | 4 | GO:0071346 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 7.06e-04 | 432 | 71 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 7.54e-04 | 12 | 71 | 2 | GO:1990034 | |
| GeneOntologyBiologicalProcess | urinary bladder smooth muscle contraction | 7.54e-04 | 12 | 71 | 2 | GO:0014832 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 8.04e-04 | 211 | 71 | 5 | GO:0060041 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 8.08e-04 | 121 | 71 | 4 | GO:0046209 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 8.60e-04 | 123 | 71 | 4 | GO:2001057 | |
| GeneOntologyBiologicalProcess | sensory organ development | 8.69e-04 | 730 | 71 | 9 | GO:0007423 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 9.12e-04 | 217 | 71 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 1.08e-03 | 465 | 71 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 1.11e-03 | 59 | 71 | 3 | GO:0045933 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.15e-03 | 133 | 71 | 4 | GO:0006939 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.16e-03 | 60 | 71 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.17e-03 | 343 | 71 | 6 | GO:0090596 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1C NTSR1 SLC6A5 CHD7 FASLG SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.18e-03 | 922 | 71 | 10 | GO:0098662 |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 1.19e-03 | 15 | 71 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid transport | 1.19e-03 | 15 | 71 | 2 | GO:2001140 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 1.32e-03 | 236 | 71 | 5 | GO:0043524 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.34e-03 | 63 | 71 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 1.35e-03 | 237 | 71 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid transport | 1.36e-03 | 16 | 71 | 2 | GO:2001138 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 1.38e-03 | 485 | 71 | 7 | GO:0050907 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 1.39e-03 | 355 | 71 | 6 | GO:0043523 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 1.43e-03 | 141 | 71 | 4 | GO:0034341 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 1.47e-03 | 65 | 71 | 3 | GO:0045429 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.58e-03 | 145 | 71 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 1.60e-03 | 67 | 71 | 3 | GO:1904407 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 1.62e-03 | 146 | 71 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 1.66e-03 | 147 | 71 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of amino acid metabolic process | 1.72e-03 | 18 | 71 | 2 | GO:0006521 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 1.75e-03 | 149 | 71 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.89e-03 | 71 | 71 | 3 | GO:0021695 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.92e-03 | 153 | 71 | 4 | GO:0051208 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 1.92e-03 | 19 | 71 | 2 | GO:0098712 | |
| GeneOntologyBiologicalProcess | positive regulation of cell size | 1.92e-03 | 19 | 71 | 2 | GO:0045793 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.70e-05 | 277 | 72 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 1.16e-04 | 5 | 72 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1C SLC6A5 UNC13C ATP2B1 ATP2B2 TENM2 ATP2B3 ATP2B4 SEZ6L | 1.71e-04 | 583 | 72 | 9 | GO:0097060 |
| GeneOntologyCellularComponent | translocon complex | 1.74e-04 | 6 | 72 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | brush border | 1.80e-04 | 152 | 72 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | apical part of cell | SLC5A12 MUC4 SLC7A11 ATP2B1 ATP2B2 CNTFR HSP90AA1 ITPK1 HSP90AB1 | 1.92e-04 | 592 | 72 | 9 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | 2.65e-04 | 487 | 72 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 4.38e-04 | 43 | 72 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | dendritic growth cone | 7.55e-04 | 12 | 72 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 8.21e-04 | 320 | 72 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.03e-03 | 223 | 72 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.38e-03 | 354 | 72 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.38e-03 | 238 | 72 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.43e-03 | 141 | 72 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 1.73e-03 | 18 | 72 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 1.73e-03 | 18 | 72 | 2 | GO:0098684 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1C TENM4 ADGRA1 ATP2B1 ATP2B2 TENM2 ATP2B3 ATP2B4 SEZ6L | 1.91e-03 | 817 | 72 | 9 | GO:0098978 |
| GeneOntologyCellularComponent | basal part of cell | 1.92e-03 | 378 | 72 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | dendrite terminus | 2.14e-03 | 20 | 72 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1C FLNB NTSR1 NAIP ATP2B1 ATP2B2 HSP90AA1 SEZ6L HSP90AB1 | 2.22e-03 | 835 | 72 | 9 | GO:0043025 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.48e-03 | 78 | 72 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | sperm plasma membrane | 2.58e-03 | 22 | 72 | 2 | GO:0097524 | |
| GeneOntologyCellularComponent | brush border membrane | 2.96e-03 | 83 | 72 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | endocytic vesicle lumen | 3.33e-03 | 25 | 72 | 2 | GO:0071682 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.68e-03 | 431 | 72 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 4.47e-03 | 29 | 72 | 2 | GO:0030867 | |
| GeneOntologyCellularComponent | cell body | CACNA1C FLNB NTSR1 NAIP ATP2B1 ATP2B2 HSP90AA1 SEZ6L HSP90AB1 | 4.50e-03 | 929 | 72 | 9 | GO:0044297 |
| Domain | ATP_Ca_trans_C | 2.15e-10 | 4 | 73 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 2.15e-10 | 4 | 73 | 4 | PF12424 | |
| Domain | P-type_ATPase_IIB | 2.15e-10 | 4 | 73 | 4 | IPR006408 | |
| Domain | ATPase_P-typ_cyto_domN | 2.35e-07 | 35 | 73 | 5 | IPR023299 | |
| Domain | P_typ_ATPase | 2.72e-07 | 36 | 73 | 5 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 2.72e-07 | 36 | 73 | 5 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.72e-07 | 36 | 73 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.14e-07 | 37 | 73 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.14e-07 | 37 | 73 | 5 | PF00122 | |
| Domain | - | 3.77e-07 | 16 | 73 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 3.77e-07 | 16 | 73 | 4 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.92e-07 | 17 | 73 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.92e-07 | 17 | 73 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 6.30e-07 | 18 | 73 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 6.30e-07 | 18 | 73 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 7.96e-07 | 19 | 73 | 4 | IPR004014 | |
| Domain | HAD-like_dom | 1.43e-05 | 79 | 73 | 5 | IPR023214 | |
| Domain | Plug_translocon | 1.51e-05 | 2 | 73 | 2 | PF10559 | |
| Domain | SecY_su_dom | 1.51e-05 | 2 | 73 | 2 | IPR023201 | |
| Domain | SecY | 1.51e-05 | 2 | 73 | 2 | PF00344 | |
| Domain | SECY_1 | 1.51e-05 | 2 | 73 | 2 | PS00755 | |
| Domain | SECY_2 | 1.51e-05 | 2 | 73 | 2 | PS00756 | |
| Domain | - | 1.51e-05 | 2 | 73 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 1.51e-05 | 2 | 73 | 2 | IPR019561 | |
| Domain | ATP2B1/4 | 1.51e-05 | 2 | 73 | 2 | IPR030319 | |
| Domain | SecY_CS | 1.51e-05 | 2 | 73 | 2 | IPR030659 | |
| Domain | SecY/SEC61-alpha | 1.51e-05 | 2 | 73 | 2 | IPR002208 | |
| Domain | Rhs_assc_core | 4.51e-05 | 3 | 73 | 2 | IPR022385 | |
| Domain | Heat_shock_protein_90_CS | 4.51e-05 | 3 | 73 | 2 | IPR019805 | |
| Domain | Tox-GHH_dom | 9.00e-05 | 4 | 73 | 2 | IPR028916 | |
| Domain | Ten_N | 9.00e-05 | 4 | 73 | 2 | IPR009471 | |
| Domain | Ten_N | 9.00e-05 | 4 | 73 | 2 | PF06484 | |
| Domain | Hsp90_fam | 9.00e-05 | 4 | 73 | 2 | IPR001404 | |
| Domain | Hsp90_N | 9.00e-05 | 4 | 73 | 2 | IPR020575 | |
| Domain | HSP90 | 9.00e-05 | 4 | 73 | 2 | PF00183 | |
| Domain | TENEURIN_N | 9.00e-05 | 4 | 73 | 2 | PS51361 | |
| Domain | Tox-GHH | 9.00e-05 | 4 | 73 | 2 | PF15636 | |
| Domain | HSP90 | 9.00e-05 | 4 | 73 | 2 | PS00298 | |
| Domain | YD | 1.50e-04 | 5 | 73 | 2 | IPR006530 | |
| Domain | - | 2.62e-04 | 32 | 73 | 3 | 3.40.1110.10 | |
| Domain | - | 2.62e-04 | 32 | 73 | 3 | 2.70.150.10 | |
| Domain | EGF_3 | 3.14e-04 | 235 | 73 | 6 | PS50026 | |
| Domain | EGF | 3.14e-04 | 235 | 73 | 6 | SM00181 | |
| Domain | EGF-like_dom | 4.27e-04 | 249 | 73 | 6 | IPR000742 | |
| Domain | EGF_1 | 4.84e-04 | 255 | 73 | 6 | PS00022 | |
| Domain | EGF-like_CS | 5.47e-04 | 261 | 73 | 6 | IPR013032 | |
| Domain | EGF_2 | 5.93e-04 | 265 | 73 | 6 | PS01186 | |
| Domain | Hydrolase_3 | 6.64e-04 | 10 | 73 | 2 | PF08282 | |
| Domain | Olfact_rcpt | 8.55e-04 | 393 | 73 | 7 | IPR000725 | |
| Domain | NHL | 1.14e-03 | 13 | 73 | 2 | PS51125 | |
| Domain | 7tm_1 | 1.25e-03 | 677 | 73 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.36e-03 | 685 | 73 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.44e-03 | 691 | 73 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.46e-03 | 692 | 73 | 9 | IPR000276 | |
| Domain | EGF | 1.50e-03 | 126 | 73 | 4 | PF00008 | |
| Domain | VWD | 1.75e-03 | 16 | 73 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.75e-03 | 16 | 73 | 2 | IPR001846 | |
| Domain | VWFD | 1.75e-03 | 16 | 73 | 2 | PS51233 | |
| Domain | VWD | 1.75e-03 | 16 | 73 | 2 | PF00094 | |
| Domain | CarboxyPept-like_regulatory | 1.97e-03 | 17 | 73 | 2 | IPR008969 | |
| Domain | HATPase_c | 2.21e-03 | 18 | 73 | 2 | SM00387 | |
| Domain | HATPase_c | 2.47e-03 | 19 | 73 | 2 | PF02518 | |
| Domain | - | 2.74e-03 | 20 | 73 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 3.02e-03 | 21 | 73 | 2 | IPR003594 | |
| Domain | TIR | 3.02e-03 | 21 | 73 | 2 | SM00255 | |
| Domain | TIR | 3.31e-03 | 22 | 73 | 2 | PF01582 | |
| Domain | Quino_amine_DH_bsu | 3.31e-03 | 22 | 73 | 2 | IPR011044 | |
| Domain | - | 3.61e-03 | 23 | 73 | 2 | 3.40.50.10140 | |
| Domain | TIR | 3.93e-03 | 24 | 73 | 2 | PS50104 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.00e-07 | 12 | 55 | 4 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.02e-07 | 14 | 55 | 4 | MM15052 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 2.58e-07 | 36 | 55 | 5 | M39831 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.25e-06 | 55 | 55 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.69e-06 | 57 | 55 | 5 | MM15643 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.40e-06 | 27 | 55 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.96e-06 | 28 | 55 | 4 | M924 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E SLC36A4 ATP8A2 SLC6A5 ABCD3 NCEH1 SLC5A12 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.49e-06 | 681 | 55 | 12 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E SLC36A4 ATP8A2 SLC6A5 ABCD3 NCEH1 SLC5A12 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.07e-05 | 736 | 55 | 12 | M27287 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.92e-05 | 103 | 55 | 5 | MM15196 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.67e-05 | 54 | 55 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.67e-05 | 54 | 55 | 4 | MM15202 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.46e-05 | 178 | 55 | 6 | M2890 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.48e-04 | 130 | 55 | 5 | M27454 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5AK2 CAPZA2 OR4C46 OR52E5 OR5A2 OR5K2 OR5K1 ATP2B1 ATP2B2 OR1L1 | 1.51e-04 | 636 | 55 | 10 | M41834 |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.16e-04 | 76 | 55 | 4 | MM15051 | |
| Pathway | WP_NRF2_PATHWAY | 2.17e-04 | 141 | 55 | 5 | M39454 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN | 2.22e-04 | 6 | 55 | 2 | M27430 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.47e-04 | 86 | 55 | 4 | M916 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 4.12e-04 | 8 | 55 | 2 | MM14950 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.48e-04 | 165 | 55 | 5 | MM15026 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.02e-04 | 176 | 55 | 5 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.18e-04 | 183 | 55 | 5 | M997 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.08e-03 | 52 | 55 | 3 | MM14949 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.12e-03 | 417 | 55 | 7 | M4072 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.13e-03 | 13 | 55 | 2 | MM14952 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.14e-03 | 203 | 55 | 5 | M5485 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 1.32e-03 | 14 | 55 | 2 | M16884 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.32e-03 | 14 | 55 | 2 | MM15029 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 1.32e-03 | 14 | 55 | 2 | MM1485 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.42e-03 | 57 | 55 | 3 | M27251 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 1.73e-03 | 16 | 55 | 2 | M48235 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.73e-03 | 16 | 55 | 2 | M16498 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 1.73e-03 | 16 | 55 | 2 | M26947 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.81e-03 | 62 | 55 | 3 | M15569 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 1.96e-03 | 17 | 55 | 2 | MM1508 | |
| Pathway | BIOCARTA_TEL_PATHWAY | 1.96e-03 | 17 | 55 | 2 | M10401 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 2.45e-03 | 19 | 55 | 2 | MM14555 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 1.79e-11 | 4 | 73 | 4 | 12209837 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 12784250 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 1.79e-11 | 4 | 73 | 4 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 1.79e-11 | 4 | 73 | 4 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 1.79e-11 | 4 | 73 | 4 | 11152753 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 1.79e-11 | 4 | 73 | 4 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 1.79e-11 | 4 | 73 | 4 | 10434059 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 15101689 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 1.79e-11 | 4 | 73 | 4 | 8634322 | |
| Pubmed | 8.91e-11 | 5 | 73 | 4 | 17938178 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 2.67e-10 | 6 | 73 | 4 | 12767889 | |
| Pubmed | 1.24e-09 | 8 | 73 | 4 | 10951186 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.69e-08 | 38 | 73 | 5 | 30786075 | |
| Pubmed | Functional requirement of p23 and Hsp90 in telomerase complexes. | 3.54e-08 | 4 | 73 | 3 | 10197982 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 19751963 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 12763866 | ||
| Pubmed | 4.08e-07 | 29 | 73 | 4 | 15071553 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18657858 | ||
| Pubmed | Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. | 4.35e-06 | 2 | 73 | 2 | 22848402 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 4.35e-06 | 2 | 73 | 2 | 3458168 | |
| Pubmed | Mechanism of dimer formation of the 90-kDa heat-shock protein. | 4.35e-06 | 2 | 73 | 2 | 7588731 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 8187550 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33080545 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 37011862 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 1313367 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 1531651 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15178683 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 37406487 | ||
| Pubmed | Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. | 4.35e-06 | 2 | 73 | 2 | 22194440 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22252018 | ||
| Pubmed | Circadian expression of 86- and 84-kDa heat shock proteins in the mouse suprachiasmatic nucleus. | 4.35e-06 | 2 | 73 | 2 | 18480550 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22841823 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25690014 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 4.35e-06 | 2 | 73 | 2 | 10748016 | |
| Pubmed | Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. | 4.35e-06 | 2 | 73 | 2 | 18347946 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19047110 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23266958 | ||
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 4.35e-06 | 2 | 73 | 2 | 12136260 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10376793 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18480044 | ||
| Pubmed | Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. | 4.35e-06 | 2 | 73 | 2 | 33179566 | |
| Pubmed | Regulation of embryonic stem cell pluripotency by heat shock protein 90. | 4.35e-06 | 2 | 73 | 2 | 22696450 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22895790 | ||
| Pubmed | Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. | 4.35e-06 | 2 | 73 | 2 | 19576239 | |
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 4.35e-06 | 2 | 73 | 2 | 16412504 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12466142 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16956963 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 2925609 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 1674727 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 2469626 | ||
| Pubmed | C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells. | 4.35e-06 | 2 | 73 | 2 | 26487798 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18820283 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 36270993 | ||
| Pubmed | Hsp90 regulation of fibroblast activation in pulmonary fibrosis. | 4.35e-06 | 2 | 73 | 2 | 28239659 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 37028636 | ||
| Pubmed | PES1 is a critical component of telomerase assembly and regulates cellular senescence. | 4.35e-06 | 2 | 73 | 2 | 31106266 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16291816 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26116539 | ||
| Pubmed | Conserved conformational changes in the ATPase cycle of human Hsp90. | 4.35e-06 | 2 | 73 | 2 | 18400751 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22019372 | ||
| Pubmed | Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. | 4.35e-06 | 2 | 73 | 2 | 16216224 | |
| Pubmed | 7.08e-06 | 18 | 73 | 3 | 23287597 | ||
| Pubmed | CACNA1C SEC61A2 FLNB PES1 CAPZA2 POLQ SEC61A1 DNAH8 ATP2B1 ATP2B2 ATP2B3 HSP90AA1 HSP90AB1 | 8.60e-06 | 1442 | 73 | 13 | 35575683 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 35325354 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28176791 | ||
| Pubmed | Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. | 1.30e-05 | 3 | 73 | 2 | 20226818 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10995457 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18550790 | ||
| Pubmed | A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation. | 1.30e-05 | 3 | 73 | 2 | 28827723 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19158073 | ||
| Pubmed | Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. | 1.30e-05 | 3 | 73 | 2 | 22849407 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 24401839 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19996089 | ||
| Pubmed | Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures. | 1.30e-05 | 3 | 73 | 2 | 15358771 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22183401 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 1827443 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11786550 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25999468 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12586360 | ||
| Pubmed | Molecular recognition via coupled folding and binding in a TPR domain. | 1.30e-05 | 3 | 73 | 2 | 15713458 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 2492519 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 1406681 | ||
| Pubmed | Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. | 1.30e-05 | 3 | 73 | 2 | 15642353 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34948386 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 29229612 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 29602239 | ||
| Pubmed | N-terminal domain of human Hsp90 triggers binding to the cochaperone p23. | 1.30e-05 | 3 | 73 | 2 | 21183720 | |
| Pubmed | Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis. | 1.30e-05 | 3 | 73 | 2 | 29386344 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22843495 | ||
| Pubmed | HSP90 affects the stability of BMAL1 and circadian gene expression. | 1.30e-05 | 3 | 73 | 2 | 24682203 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 33098669 | ||
| Pubmed | Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. | 1.30e-05 | 3 | 73 | 2 | 16531226 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 33145341 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 38316082 | ||
| Pubmed | HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. | 1.30e-05 | 3 | 73 | 2 | 29768689 | |
| Pubmed | Hsp90 activity is necessary to acquire a proper neuronal polarization. | 1.30e-05 | 3 | 73 | 2 | 24286867 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17689535 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20211863 | ||
| Interaction | C17orf78 interactions | 5.09e-08 | 12 | 66 | 4 | int:C17orf78 | |
| Interaction | HSD17B6 interactions | 1.39e-07 | 15 | 66 | 4 | int:HSD17B6 | |
| Interaction | CYP2B6 interactions | 1.86e-06 | 8 | 66 | 3 | int:CYP2B6 | |
| Interaction | LILRB4 interactions | 2.02e-06 | 28 | 66 | 4 | int:LILRB4 | |
| Interaction | UNC13C interactions | 7.23e-06 | 12 | 66 | 3 | int:UNC13C | |
| Interaction | HCRTR2 interactions | 7.92e-06 | 39 | 66 | 4 | int:HCRTR2 | |
| Interaction | C5AR1 interactions | 1.12e-05 | 154 | 66 | 6 | int:C5AR1 | |
| Interaction | ENTPD7 interactions | 2.72e-05 | 53 | 66 | 4 | int:ENTPD7 | |
| Interaction | FPR2 interactions | 8.95e-05 | 138 | 66 | 5 | int:FPR2 | |
| Interaction | EIF2AK1 interactions | 1.04e-04 | 28 | 66 | 3 | int:EIF2AK1 | |
| Interaction | FZD7 interactions | 1.19e-04 | 77 | 66 | 4 | int:FZD7 | |
| Interaction | CLGN interactions | 1.19e-04 | 235 | 66 | 6 | int:CLGN | |
| Interaction | LGALS9 interactions | FLNB TBC1D15 NTSR1 SLC7A11 ATP2B1 ATP2B4 TSPAN3 HSP90AA1 HSP90AB1 | 1.21e-04 | 588 | 66 | 9 | int:LGALS9 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 7.24e-05 | 138 | 73 | 4 | chr9q33 | |
| Cytoband | 3q11.2 | 7.91e-04 | 26 | 73 | 2 | 3q11.2 | |
| Cytoband | 22q12.1 | 1.20e-03 | 32 | 73 | 2 | 22q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 3.38e-03 | 54 | 73 | 2 | chr3q11 | |
| GeneFamily | ATPases Ca2+ transporting | 7.58e-09 | 9 | 52 | 4 | 1209 | |
| GeneFamily | Heat shock 90kDa proteins | 8.07e-05 | 5 | 52 | 2 | 586 | |
| GeneFamily | Olfactory receptors, family 5 | 3.00e-04 | 112 | 52 | 4 | 152 | |
| GeneFamily | DNA helicases | 1.07e-03 | 17 | 52 | 2 | 1167 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 6.49e-03 | 42 | 52 | 2 | 602 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.19e-06 | 438 | 69 | 9 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 2.27e-06 | 440 | 69 | 9 | MM832 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 1.34e-05 | 115 | 69 | 5 | M7995 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-07 | 187 | 73 | 6 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.97e-07 | 198 | 73 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-06 | 168 | 73 | 5 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 174 | 73 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 174 | 73 | 5 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 178 | 73 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 182 | 73 | 5 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 182 | 73 | 5 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.56e-05 | 191 | 73 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.63e-05 | 193 | 73 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-05 | 194 | 73 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-05 | 194 | 73 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 196 | 73 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Drug | 1sqc | 1.90e-08 | 10 | 72 | 4 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 2.98e-08 | 11 | 72 | 4 | CID000008718 | |
| Drug | sanguinarine | 3.54e-08 | 60 | 72 | 6 | CID000005154 | |
| Drug | 1vyq | 4.46e-08 | 12 | 72 | 4 | CID004369390 | |
| Drug | Ro 46861 | 4.46e-08 | 12 | 72 | 4 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 6.43e-08 | 13 | 72 | 4 | CID000122783 | |
| Drug | p-hydroxyhippuric acid | 8.98e-08 | 14 | 72 | 4 | CID000151012 | |
| Drug | AC1L88YH | 2.12e-07 | 17 | 72 | 4 | CID000374551 | |
| Drug | benzoquinone | 3.19e-07 | 209 | 72 | 8 | CID000004650 | |
| Drug | AC1L1G0K | 4.70e-07 | 49 | 72 | 5 | CID000003473 | |
| Drug | 2brh | 5.28e-07 | 21 | 72 | 4 | CID000848641 | |
| Drug | AC1L25Y6 | 7.78e-07 | 23 | 72 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 7.78e-07 | 23 | 72 | 4 | CID000165791 | |
| Drug | AC1L1JAO | 1.01e-06 | 57 | 72 | 5 | CID000004955 | |
| Drug | AC1NSKPI | 1.01e-06 | 57 | 72 | 5 | CID005311482 | |
| Drug | cyhexatin | 1.11e-06 | 25 | 72 | 4 | CID005364545 | |
| Drug | dodecyl ether | 1.30e-06 | 26 | 72 | 4 | CID000020667 | |
| Drug | octaethylene glycol | 2.06e-06 | 29 | 72 | 4 | CID000078798 | |
| Drug | fluo-3 | 2.45e-06 | 122 | 72 | 6 | CID000104978 | |
| Drug | L-beta-aspartyl phosphate | 2.64e-06 | 69 | 72 | 5 | CID000000832 | |
| Drug | monobromobimane | 3.26e-06 | 72 | 72 | 5 | CID000114810 | |
| Drug | AC1L1IZE | 3.70e-06 | 131 | 72 | 6 | CID000004799 | |
| Drug | fluorescamine | 4.47e-06 | 35 | 72 | 4 | CID000037927 | |
| Drug | butyrate | ZACN SLC6A5 SLC5A12 POLQ TERT ME2 MUC4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 | 4.71e-06 | 767 | 72 | 12 | CID000000264 |
| Drug | mag-fura-2 | 5.61e-06 | 37 | 72 | 4 | CID000123839 | |
| Drug | gramicidin s | 5.61e-06 | 37 | 72 | 4 | CID000073357 | |
| Drug | TBHQ | 5.66e-06 | 141 | 72 | 6 | CID000016043 | |
| Drug | lycopene | 6.14e-06 | 143 | 72 | 6 | ctd:C015329 | |
| Drug | carbidine | 7.71e-06 | 40 | 72 | 4 | CID000065684 | |
| Drug | Bay K 8644 | 8.08e-06 | 150 | 72 | 6 | CID000002303 | |
| Drug | xenon | 8.77e-06 | 88 | 72 | 5 | CID000023991 | |
| Drug | AC1L2J0W | 9.39e-06 | 42 | 72 | 4 | CID000072957 | |
| Drug | C12E8 | 9.39e-06 | 42 | 72 | 4 | CID000123921 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 9.86e-06 | 2 | 72 | 2 | DB07877 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 9.86e-06 | 2 | 72 | 2 | DB07594 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 9.86e-06 | 2 | 72 | 2 | DB02754 | |
| Drug | Geldanamycin | 9.86e-06 | 2 | 72 | 2 | DB02424 | |
| Drug | caloxin 1b1 | 9.86e-06 | 2 | 72 | 2 | ctd:C510327 | |
| Drug | linopirdine | 1.03e-05 | 43 | 72 | 4 | CID000003932 | |
| Drug | AC1L1KS5 | 1.04e-05 | 334 | 72 | 8 | CID000005631 | |
| Drug | caffeine | CACNA1C SEC61A2 PES1 AGTR2 INO80 SEC61A1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.05e-05 | 562 | 72 | 10 | CID000002519 |
| Drug | oxalate | 1.09e-05 | 158 | 72 | 6 | CID000000971 | |
| Drug | agelasine B | 1.36e-05 | 46 | 72 | 4 | CID006439899 | |
| Drug | acetyl phosphate | 1.48e-05 | 98 | 72 | 5 | CID000000186 | |
| Drug | indo-1 | 1.56e-05 | 99 | 72 | 5 | CID000105060 | |
| Drug | Zymosan | 1.76e-05 | 172 | 72 | 6 | ctd:D015054 | |
| Drug | TMB-8 | 2.01e-05 | 176 | 72 | 6 | CID000005494 | |
| Drug | 1,4-dibromobutane | 2.39e-05 | 53 | 72 | 4 | CID000008056 | |
| Drug | Calcium | 2.47e-05 | 493 | 72 | 9 | ctd:D002118 | |
| Drug | dihydropyridine | 3.37e-05 | 193 | 72 | 6 | CID000104822 | |
| Drug | toxaphene | 3.43e-05 | 58 | 72 | 4 | CID005284469 | |
| Drug | ethylketocyclazocine | 3.43e-05 | 58 | 72 | 4 | CID000135018 | |
| Drug | sodium | CACNA1C ZACN ATP8A2 AGTR2 SLC6A5 SLC5A12 SLC7A11 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 | 3.73e-05 | 944 | 72 | 12 | CID000000923 |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 1507_UP | |
| Drug | EGTA-AM | 4.46e-05 | 62 | 72 | 4 | CID000121907 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 4.80e-05 | 125 | 72 | 5 | CID000002603 | |
| Drug | C13932 | 4.85e-05 | 206 | 72 | 6 | CID000168297 | |
| Drug | phosphocreatine disodium | 4.98e-05 | 126 | 72 | 5 | CID000000587 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 5.89e-05 | 4 | 72 | 2 | ctd:C576667 | |
| Drug | NSC-121444 | 5.89e-05 | 4 | 72 | 2 | CID000201049 | |
| Drug | chlordecone | 6.06e-05 | 67 | 72 | 4 | CID000000299 | |
| Drug | NDGA | 6.31e-05 | 216 | 72 | 6 | CID000004534 | |
| Drug | strontium | 6.42e-05 | 68 | 72 | 4 | CID000104798 | |
| Drug | Arachidonic Acid | 6.47e-05 | 217 | 72 | 6 | ctd:D016718 | |
| Drug | tBuBHQ | 6.80e-05 | 69 | 72 | 4 | CID000002374 | |
| Drug | lanthanum | 7.17e-05 | 136 | 72 | 5 | CID000023926 | |
| Drug | caged ATP | 7.20e-05 | 70 | 72 | 4 | CID000123806 | |
| Drug | K-Cl | CACNA1C POLQ TERT ATP2B1 ATP2B2 ATP2B3 ATP2B4 PTGS1 HSP90AB1 | 7.29e-05 | 567 | 72 | 9 | CID000004873 |
| Drug | BAPTA | 7.39e-05 | 324 | 72 | 7 | CID000104751 | |
| Drug | Pyrethroids | 7.61e-05 | 71 | 72 | 4 | CID000005053 | |
| Drug | cadmium | 7.77e-05 | 443 | 72 | 8 | CID000002514 | |
| Drug | cocaethylene | 8.48e-05 | 73 | 72 | 4 | CID000002825 | |
| Drug | clotrimazole | 9.09e-05 | 143 | 72 | 5 | CID000002812 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 9.58e-05 | 233 | 72 | 6 | CID000005114 | |
| Drug | nimodipine | 9.71e-05 | 145 | 72 | 5 | CID000004497 | |
| Drug | acetate | 1.11e-04 | 599 | 72 | 9 | CID000000175 | |
| Drug | DCCD | 1.17e-04 | 151 | 72 | 5 | CID000010868 | |
| Drug | compound 48/80 | 1.17e-04 | 151 | 72 | 5 | CID000104735 | |
| Drug | Ovalbumin | 1.33e-04 | 82 | 72 | 4 | ctd:D010047 | |
| Drug | XeC compound | 1.47e-04 | 84 | 72 | 4 | CID000005701 | |
| Drug | cobaltiprotoporphyrin | 1.50e-04 | 159 | 72 | 5 | ctd:C007095 | |
| Drug | S)-HPMPA | 2.01e-04 | 36 | 72 | 3 | CID000072253 | |
| Drug | NSC330499 | 2.05e-04 | 7 | 72 | 2 | CID000433447 | |
| Drug | methylthiourea | 2.05e-04 | 7 | 72 | 2 | CID002723704 | |
| Drug | Sulfasalazine | 2.05e-04 | 7 | 72 | 2 | DB00795 | |
| Drug | AC1MMLID | 2.08e-04 | 92 | 72 | 4 | CID000013245 | |
| Drug | tsuwabukinonol | 2.18e-04 | 37 | 72 | 3 | CID006440419 | |
| Drug | NSC19448 | 2.27e-04 | 273 | 72 | 6 | CID000003054 | |
| Drug | NSC 226902 | 2.36e-04 | 38 | 72 | 3 | CID000010118 | |
| Drug | nitrous oxide | 2.45e-04 | 96 | 72 | 4 | CID000000948 | |
| Drug | isoflurane | 2.55e-04 | 279 | 72 | 6 | CID000003763 | |
| Drug | gaillardin | 2.73e-04 | 8 | 72 | 2 | CID000267247 | |
| Drug | chloranylsilane | 2.73e-04 | 8 | 72 | 2 | CID000061622 | |
| Drug | ethenzamide | 2.73e-04 | 8 | 72 | 2 | CID000003282 | |
| Drug | phenyldichloroarsine | 2.73e-04 | 8 | 72 | 2 | CID000012762 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 2.80e-04 | 182 | 72 | 5 | 2688_UP | |
| Drug | FCCP | 2.98e-04 | 101 | 72 | 4 | CID000003330 | |
| Drug | CTK8G2960 | 3.10e-04 | 186 | 72 | 5 | CID005361912 | |
| Drug | 6-anilino-5,8-quinolinedione | 3.50e-04 | 9 | 72 | 2 | ctd:C041715 | |
| Drug | 5,8-quinolinedione | 3.50e-04 | 9 | 72 | 2 | CID000388306 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.60e-10 | 6 | 71 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.26e-05 | 19 | 71 | 3 | DOID:4928 (is_marker_for) | |
| Disease | Immunologic Deficiency Syndromes | 2.28e-05 | 23 | 71 | 3 | C0021051 | |
| Disease | bipolar I disorder | 2.34e-05 | 141 | 71 | 5 | EFO_0009963 | |
| Disease | Manic | 3.84e-05 | 78 | 71 | 4 | C0338831 | |
| Disease | Antihypertensive use measurement | 4.36e-05 | 265 | 71 | 6 | EFO_0009927 | |
| Disease | melanoma (is_implicated_in) | 7.57e-05 | 34 | 71 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 9.00e-05 | 36 | 71 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Alzheimer disease, APOE carrier status | 9.37e-05 | 98 | 71 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | Hypertensive disease | 9.69e-05 | 190 | 71 | 5 | C0020538 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 1.19e-04 | 7 | 71 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | renovascular hypertension (implicated_via_orthology) | 2.03e-04 | 9 | 71 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | cystic fibrosis, lung disease severity measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0007744, MONDO_0009061 | |
| Disease | otitis media (is_marker_for) | 2.54e-04 | 10 | 71 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 2.54e-04 | 10 | 71 | 2 | DOID:11204 (is_marker_for) | |
| Disease | chronic kidney disease (implicated_via_orthology) | 3.71e-04 | 12 | 71 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 4.56e-04 | 62 | 71 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Coronary Arteriosclerosis | 5.24e-04 | 65 | 71 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 5.24e-04 | 65 | 71 | 3 | C1956346 | |
| Disease | unipolar depression, bipolar disorder | 5.55e-04 | 156 | 71 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | phosphatidylcholine measurement | 6.18e-04 | 284 | 71 | 5 | EFO_0010226 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 6.24e-04 | 69 | 71 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Nonorganic psychosis | 6.24e-04 | 69 | 71 | 3 | C0349204 | |
| Disease | Manic Disorder | 6.79e-04 | 71 | 71 | 3 | C0024713 | |
| Disease | Contact Dermatitis | 6.79e-04 | 71 | 71 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 6.79e-04 | 71 | 71 | 3 | C0162351 | |
| Disease | Antibody Deficiency Syndrome | 7.58e-04 | 17 | 71 | 2 | C0003257 | |
| Disease | Bipolar Disorder | 1.02e-03 | 477 | 71 | 6 | C0005586 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 1.05e-03 | 20 | 71 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | red blood cell density measurement | 1.23e-03 | 880 | 71 | 8 | EFO_0007978 | |
| Disease | Schizophrenia | 1.25e-03 | 883 | 71 | 8 | C0036341 | |
| Disease | Reperfusion Injury | 1.31e-03 | 89 | 71 | 3 | C0035126 | |
| Disease | taurine measurement | 1.79e-03 | 26 | 71 | 2 | EFO_0010536 | |
| Disease | Psychotic Disorders | 1.88e-03 | 101 | 71 | 3 | C0033975 | |
| Disease | pancreatic cancer (is_marker_for) | 1.88e-03 | 101 | 71 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Neoplasm Metastasis | 1.88e-03 | 217 | 71 | 4 | C0027627 | |
| Disease | Age related macular degeneration | 2.38e-03 | 30 | 71 | 2 | C0242383 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 2.40e-03 | 110 | 71 | 3 | EFO_0003095, MONDO_0005148 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEVVVVVLGYVYRAK | 96 | O60637 | |
| VVLGYVYRAKVENEV | 101 | O60637 | |
| ITQYIQSYKGFVDIT | 236 | Q13075 | |
| YTVLLIQTDKGSVYI | 356 | Q8NDM7 | |
| ITLVTCVYFLGTYVQ | 186 | Q86SQ6 | |
| YYIIFVIGFLVNIVV | 51 | P50052 | |
| IQSITFLYEIYLKGI | 1001 | Q9P2D1 | |
| IYIQYFVKFFIIGVT | 411 | P20020 | |
| YVQYFVKFFIIGVTV | 436 | Q01814 | |
| VQYFVKFFIIGVTVL | 411 | Q16720 | |
| IYIQYFVKFFIIGIT | 401 | P23634 | |
| GNIVYTYVVVTVCLK | 1001 | Q9NTI2 | |
| VQVFTIGSVLISYLY | 206 | Q8NHB8 | |
| VVITSYQLVVQDVKY | 626 | Q9ULG1 | |
| VIEAYKGQTTLIQYT | 4961 | Q99102 | |
| VGFYSAYLVAEKVVV | 131 | P08238 | |
| VLYKVFVVGESYTVV | 196 | Q13572 | |
| ITGALQIYTDIIYIF | 286 | Q969X1 | |
| YSKVLVTAVYLALFV | 61 | P30989 | |
| VTYVVKERGDYVLAV | 2571 | O75369 | |
| FVVFFVIYIITVVGY | 26 | A6NHA9 | |
| LISYGYIVAAVVKIS | 216 | Q8NGI9 | |
| VIVSIEYRLVPKVYF | 141 | Q6PIU2 | |
| SIFEQIYEVKYTGKV | 776 | Q96JB1 | |
| VYNLVYVEKISFLVA | 271 | Q6NSJ5 | |
| KIVIEEYVQQLSGYF | 341 | P23219 | |
| GLQGVKVTYTVQYFI | 61 | Q9UHF4 | |
| VQVFTIGSVLISYLY | 206 | Q8NHB7 | |
| GTIEYQTTFIVYIAV | 5616 | Q96RW7 | |
| IAIGQTDNIIYVYKI | 81 | Q9UG01 | |
| YTVKDQIATIIYTVL | 316 | Q8NH94 | |
| NLIFTGLVVIFSYIY | 206 | Q8NH90 | |
| QVIQKETVGGTTYFY | 391 | Q58A45 | |
| VAVAVSVVYIYNIFK | 346 | Q9HB29 | |
| LQAIVEYAYTGTVFI | 86 | Q9NXS3 | |
| VTVGKFYATFLIQEY | 1661 | Q13936 | |
| SVVIYDFIQSYKILL | 1961 | O75417 | |
| LVYYIVTGEQTAELV | 541 | P01031 | |
| TITDAYAGKEYIIQV | 266 | P26992 | |
| EVSINIAIKVTEYLY | 521 | P23368 | |
| TVYFIASVVVLYNVE | 246 | O00423 | |
| VGFYSAYLVAEKVTV | 136 | P07900 | |
| LGKYVLYEVQVLAFT | 1266 | Q58EX2 | |
| GYIDISVIGFSYVQI | 206 | Q8NH55 | |
| VAVYIIVDESNVKYF | 201 | A6ND36 | |
| VKLGLTVVYTVFYAL | 41 | O60478 | |
| EKLYLVQGTQVYVFL | 316 | P02790 | |
| NVTVYTGYGVELQVK | 311 | Q9BYH1 | |
| VTIIYQYFEIFVKEQ | 451 | Q9H9S3 | |
| AVITEINGYKINVYF | 551 | B5MCY1 | |
| VVYFTATFPYVVLVI | 421 | Q9Y345 | |
| KFGVIYYDINQIITT | 2131 | Q9NT68 | |
| VIYGIAVNIKTAEIY | 176 | Q96AB6 | |
| IDSIIAKYLATVVGY | 316 | P28288 | |
| TQVVGILKIQVHYYE | 186 | P47755 | |
| YTEAISVGEKLYQFI | 126 | Q9H9A5 | |
| INYKVLLVSTEVTYF | 61 | Q5VVB8 | |
| IVTIGYVLTNVAYFT | 276 | Q9UPY5 | |
| IGVYYIDHINKTTQI | 71 | Q6AWC2 | |
| FEYVESVVYQILIDK | 331 | Q8NB66 | |
| VFLSIKGIYYQAEVL | 181 | O00541 | |
| VTIIYQYFEIFVKEQ | 451 | P61619 | |
| GKFGVIYYDINQIIT | 2121 | Q6N022 | |
| VVSGKIIYEQEGVYI | 6 | Q8TC07 | |
| LVINETGLYFVYSKV | 181 | P48023 | |
| RYIVKVAYEQDGVIV | 181 | A2A288 | |
| VVNEIVSVKREYVVY | 191 | Q401N2 | |
| FQTYDTEYLKVGFII | 741 | O95789 | |
| VTYVYQLIGDDVKVE | 161 | Q9UBQ0 | |
| YIVQTILYTGVVVYA | 131 | Q1EHB4 | |
| VLVVSVVAVLVYKFY | 641 | O00206 | |
| VKILYSFGIFVTYSI | 351 | Q6YBV0 | |
| LYFVKVDVTGAYDTI | 706 | O14746 | |
| IFLQEVITTVYGYKV | 2386 | Q9Y493 |